Modern Healthcare June 17, 2020

MD Anderson Cancer Center said on Tuesday that its oncologists will be able to access a database to help them identify approved treatments and available clinical trials based on the genetic alterations detected in their patients’ cancers.

MD Anderson developed the Precision Oncology Decision Support System via Philips’ oncology informatics solution. Given the rapid pace of genomic advancements and the increasing availability of new precision oncology options, MD Anderson decided to run PODS on Philips’ informatics solution and offer clinicians a streamlined view of the therapeutic and study options in the context of patients’ genomic profile.

“Today, pathologists...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Pharma / Biotech, Physician, Precision Medicine, Provider
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article